ADVB (Advanced Biomed Inc. Common Stock) Stock Analysis - Financials

Advanced Biomed Inc. Common Stock (ADVB) is a publicly traded Healthcare sector company. As of May 21, 2026, ADVB trades at $4.36 with a market cap of $7.47M and a P/E ratio of -28.16. ADVB moved +0.00% today. Year to date, ADVB is -34.05%; over the trailing twelve months it is -81.51%. Its 52-week range spans $3.61 to $82.00. Rallies surfaces ADVB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are ADVB's key financials?

ADVB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ADVB recently traded at $4.36. Market cap is $7.47M. P/E ratio is -28.16. Revenue is $0.

ADVB Key Metrics

Key financial metrics for ADVB
MetricValue
Price$4.36
Market Cap$7.47M
P/E Ratio-28.16
EPS$-0.16
Dividend Yield0.00%
52-Week High$82.00
52-Week Low$3.61
Volume516
Avg Volume0
Revenue (TTM)$0
Net Income$-3.26M
Gross Margin0.00%

ADVB Annual Financials

YearRevenueNet IncomeEPS
2025$0$-3.26M$-0.16

Latest ADVB News

ADVB Analyst Consensus

ADVB analyst coverage data. Average price target: $0.00.

Common questions about ADVB

What are ADVB's key financials?
ADVB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ADVB recently traded at $4.36. Market cap is $7.47M. P/E ratio is -28.16. Revenue is $0.
Is ADVB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ADVB. It does not provide personalized investment advice.
ADVB

ADVB